Management of Animal Bite: A Challenge to Health System – A Case Report
Abstract
Background: Anti-rabies vaccine (ARV) and rabies immunoglobulin are given as post-exposure prophylaxis in animal bite cases to prevent the fatal disease of rabies. In most cases, especially category III bite cases, these need to be administered. Here we have reported case of animal bite presented at a rural health center.
Case Description: A 33-year-old female visited a Center for Rural Health AIIMS (CRHA) on July 22, 2023, with a complaint of a dog bite on the right arm and right ring finger 1 day back. Though the patient had washed the site of the bite under running water, she gave a history of applying turmeric paste. There was pain and swelling at the bite site along with a history of bleeding from bite sites.
Management: Post-exposure prophylaxis following intramuscular Essen regimen was prescribed based on the category of bite (category III). Tetanus toxoid 0.5 ml IM was administered. Symptomatic treatment was given for pain and swelling. The patient was referred for human rabies immunoglobulin (HRIG) as it was not available at CRHA. The patient could receive the first 3 doses of ARV but due to limited availability, she was referred for further doses.
Conclusion: The case report highlights the need for the provision of ARV and HRIG at health centers since the out-of-pocket expenditure is high.
How to cite this article:
Katre R, Singh P, Yadav P, Bhadoria A S, Aggarwal P. Management of Animal Bite: A Challenge to Health System – A Case Report. APCRI J. 2024;26(1):18-21.
DOI: https://doi.org/10.24321/0973.5038.202405
References
Benmaamar R, Astray RM, Wagner R, Pereira CA. High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector. J Biotechnol. 2009;139(4):283-90. [PubMed] [Google Scholar]
Menezes R. Rabies in India. CMAJ. 2008 Feb 26;178(5):564-6. [PubMed] [Google Scholar]
World Health Organization [Internet]. WHO expert consultation on rabies, third report. WHO Technical Report Series, No. 1012. Geneva: World Health Organization; 2018 [cited 2024 Apr 23]. Available from: https://iris.who.int/bitstream/handle/10665/272364/9789241210218-eng.pdf?sequence=1
Shantavasinkul P, Wilde H. Postexposure prophylaxis for rabies in resource-limited/poor countries. Adv Virus Res. 2011;79:291-307. [PubMed] [Google Scholar]
Chatterjee P. India’s ongoing war against rabies. Bull World Health Organ. 2009 Dec;87(12):890-1. [PubMed] [Google Scholar]
World Health Organization [Internet]. Rabies in India; [cited 2024 Apr 22]. Available from: https://www. who.int/india/health-topics/rabies
World Health Organization [Internet]. Rabies; [cited 2024 Apr 22]. Available from: https://www.who.int/health-topics/rabies#tab=tab_1
Sujitha P, Swetha NB, Gopalakrishnan S. Cost analysis of rabies prophylaxis in India. Int J Community Med Public Health [Internet]. 2020 [cited 2024 Apr 23];7(9):3403-8. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/6634 [Google Scholar]
National Rabies Control Program [Internet]. About NAPRE; [cited 2024 Apr 24]. Available from: https://rabiesfreeindia.mohfw.gov.in/About-NAPRE